ORMP vs. AYTU

Last updated Apr 1, 2026

Compare and contrast key facts about Oramed Pharmaceuticals Inc. (ORMP) and Aytu BioPharma, Inc. (AYTU).

Performance

ORMP vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oramed Pharmaceuticals Inc. (ORMP) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

ORMP vs. AYTU - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ORMP Oramed Pharmaceuticals Inc.	27.97%	17.77%	4.76%	-80.80%	-15.76%	236.79%	-17.67%	71.67%	-66.67%	43.31%
AYTU Aytu BioPharma, Inc.	5.00%	52.94%	-40.14%	-24.87%	-86.00%	-77.42%	-38.35%	22.41%	-98.22%	-88.85%

Fundamentals

EPS ORMP : $1.03 AYTU : -$2.02
PS Ratio ORMP : 72.58 AYTU : 0.53
Total Revenue (TTM) ORMP : $2.00M AYTU : $62.64M
Gross Profit (TTM) ORMP : -$79.00K AYTU : $41.34M
EBITDA (TTM) ORMP : $58.42M AYTU : -$17.24M

Returns By Period

In the year-to-date period, ORMP achieves a 27.97% return, which is significantly higher than AYTU's 5.00% return.

ORMP

• 1D: 3.66%
• 1M: -0.44%
• YTD: 27.97%
• 6M: 38.15%
• 1Y: 70.42%
• 3Y*: 18.71%
• 5Y*: -18.59%
• 10Y*: -6.63%

AYTU

• 1D: 3.61%
• 1M: 6.23%
• YTD: 5.00%
• 6M: 45.21%
• 1Y: 127.50%
• 3Y*: 6.82%
• 5Y*: -55.20%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ORMP vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ORMP

ORMP Risk / Return Rank: 83
ORMP Sharpe Ratio Rank: 84
ORMP Sortino Ratio Rank: 83
ORMP Omega Ratio Rank: 77
ORMP Calmar Ratio Rank: 88
ORMP Martin Ratio Rank: 84

AYTU

AYTU Risk / Return Rank: 86
AYTU Sharpe Ratio Rank: 76
AYTU Sortino Ratio Rank: 92
AYTU Omega Ratio Rank: 90
AYTU Calmar Ratio Rank: 85
AYTU Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ORMP vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oramed Pharmaceuticals Inc. (ORMP) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ORMP	AYTU	Difference
Sharpe ratio Return per unit of total volatility	1.45	1.09	+0.37
Sortino ratio Return per unit of downside risk	2.28	3.01	-0.73
Omega ratio Gain probability vs. loss probability	1.26	1.39	-0.13
Calmar ratio Return relative to maximum drawdown	3.44	2.96	+0.48
Martin ratio Return relative to average drawdown	7.67	7.81	-0.14
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ORMP vs. AYTU - Sharpe Ratio Comparison

The current ORMP Sharpe Ratio is 1.45, which is higher than the AYTU Sharpe Ratio of 1.09. The chart below compares the historical Sharpe Ratios of ORMP and AYTU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ORMP	AYTU	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.45	1.09	+0.37
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.23	-0.65	+0.42
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.09	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.06	-0.36	+0.29

Correlation

The correlation between ORMP and AYTU is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ORMP vs. AYTU - Dividend Comparison

ORMP's dividend yield for the trailing twelve months is around 7.35%, while AYTU has not paid dividends to shareholders.

	TTM
ORMP Oramed Pharmaceuticals Inc.	7.35%
AYTU Aytu BioPharma, Inc.	0.00%

Drawdowns

ORMP vs. AYTU - Drawdown Comparison

The maximum ORMP drawdown since its inception was -94.25%, smaller than the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for ORMP and AYTU.

Drawdown Indicators

	ORMP	AYTU	Difference
Max Drawdown Largest peak-to-trough decline	-94.25%	-100.00%	+5.75%
Max Drawdown (1Y) Largest decline over 1 year	-18.89%	-42.47%	+23.58%
Max Drawdown (5Y) Largest decline over 5 years	-94.25%	-99.34%	+5.09%
Max Drawdown (10Y) Largest decline over 10 years	-94.25%	—	—
Current Drawdown Current decline from peak	-87.74%	-100.00%	+12.26%
Average Drawdown Average peak-to-trough decline	-70.62%	-95.05%	+24.43%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.48%	16.07%	-7.59%

Volatility

ORMP vs. AYTU - Volatility Comparison

Oramed Pharmaceuticals Inc. (ORMP) has a higher volatility of 14.54% compared to Aytu BioPharma, Inc. (AYTU) at 9.71%. This indicates that ORMP's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ORMP	AYTU	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.54%	9.71%	+4.83%
Volatility (6M) Calculated over the trailing 6-month period	37.14%	39.38%	-2.24%
Volatility (1Y) Calculated over the trailing 1-year period	48.81%	117.87%	-69.06%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	81.19%	85.83%	-4.64%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	72.78%	190.04%	-117.26%

Financials